MTOR and Alzheimer disease: Prompt cognitive recovery and severe mTOR inhibition has also been demonstrated in other early onset (EOAD) and late-onset Alzheimer’s disease (LOAD) mouse models upon prompt treatment for 13 to 16 weeks after clinical onset [22,25].